BenzingaOctober 20, 2026 at 9:11 AM NY7 Days Ago
Why Is Actinium Pharmaceuticals Stock Gaining Tuesday?
Actinium Pharmaceuticals shares jump 9% after positive Phase 1 ATNM-400 trial results in prostate cancer show early safety and retention.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
